Figure 1.
Overview of cytogenetic aberrations and concurrent mutations in mutant TP53 AML/MDS-EB (n = 230). Each column represents an individual patient, and the presence of the aberration is indicated in blue. The upper panel shows the cytogenetic aberrations, and the lower panel shows the concurrent mutations. Patients with MDS-EB or bi-allelic TP53 mutant status are also indicated in blue. In case of failed cytogenetics, the cytogenetic aberrations were considered negative.

Overview of cytogenetic aberrations and concurrent mutations in mutant TP53 AML/MDS-EB (n = 230). Each column represents an individual patient, and the presence of the aberration is indicated in blue. The upper panel shows the cytogenetic aberrations, and the lower panel shows the concurrent mutations. Patients with MDS-EB or bi-allelic TP53 mutant status are also indicated in blue. In case of failed cytogenetics, the cytogenetic aberrations were considered negative.

Close Modal

or Create an Account

Close Modal
Close Modal